68 research outputs found
Heavy Lift Launch Capability with a New Hydrocarbon Engine
The Advanced Concepts Office at NASA's George C. Marshall Space Flight Center was tasked to define the thrust requirement of a new liquid oxygen rich staged combustion cycle hydrocarbon engine that could be utilized in a launch vehicle to meet NASA s future heavy lift needs. Launch vehicle concepts were sized using this engine for different heavy lift payload classes. Engine out capabilities for one of the heavy lift configurations were also analyzed for increased reliability that may be desired for high value payloads or crewed missions. The applicability for this engine in vehicle concepts to meet military and commercial class payloads comparable to current ELV capability was also evaluated
NASA Advanced Concepts Office, Earth-To-Orbit Team Design Process and Tools
The Earth to Orbit (ETO) Team of the Advanced Concepts Office (ACO) at NASA Marshal Space Flight Center (MSFC) is considered the preeminent group to go to for prephase A and phase A concept definition. The ACO team has been at the forefront of a multitude of launch vehicle studies determining the future direction of the Agency as a whole due, in part, to their rapid turnaround time in analyzing concepts and their ability to cover broad trade spaces of vehicles in that limited timeframe. Each completed vehicle concept includes a full mass breakdown of each vehicle to tertiary subsystem components, along with a vehicle trajectory analysis to determine optimized payload delivery to specified orbital parameters, flight environments, and delta v capability. Additionally, a structural analysis of the vehicle based on material properties and geometries is performed as well as an analysis to determine the flight loads based on the trajectory outputs. As mentioned, the ACO Earth to Orbit Team prides themselves on their rapid turnaround time and often need to fulfill customer requests within limited schedule or little advanced notice. Due to working in this fast paced environment, the ETO team has developed some finely honed skills and methods to maximize the delivery capability to meet their customer needs. This paper will describe the interfaces between the 3 primary disciplines used in the design process; weights and sizing, trajectory, and structural analysis, as well as the approach each discipline employs to streamline their particular piece of the design process
The InfraRed Imaging Spectrograph (IRIS) for TMT: latest science cases and simulations
The Thirty Meter Telescope (TMT) first light instrument IRIS (Infrared
Imaging Spectrograph) will complete its preliminary design phase in 2016. The
IRIS instrument design includes a near-infrared (0.85 - 2.4 micron) integral
field spectrograph (IFS) and imager that are able to conduct simultaneous
diffraction-limited observations behind the advanced adaptive optics system
NFIRAOS. The IRIS science cases have continued to be developed and new science
studies have been investigated to aid in technical performance and design
requirements. In this development phase, the IRIS science team has paid
particular attention to the selection of filters, gratings, sensitivities of
the entire system, and science cases that will benefit from the parallel mode
of the IFS and imaging camera. We present new science cases for IRIS using the
latest end-to-end data simulator on the following topics: Solar System bodies,
the Galactic center, active galactic nuclei (AGN), and distant
gravitationally-lensed galaxies. We then briefly discuss the necessity of an
advanced data management system and data reduction pipeline.Comment: 15 pages, 7 figures, SPIE (2016) 9909-0
Recommended from our members
Employing citizen science to understand the contemporary needs of older adults accessing and using technology in a pandemic
The ‘Adjust Tech, Accessible Technology’ (ATAT) project (2020) aims to understand via citizen science what basic adjustments are required by older adults; to access and use affordable technologies and software - such as mobile apps.
Facilitating this multi-and-inter-disciplinary team of researchers from the fields of gerontology, gerontechnology, and human computer interaction (HCI), the research team are employing citizen science across three stages: 1. Co-creation, 2. Co-design and 3. Co-evaluation. Implementing this approach by adults aged 50+ years who are geographically displaced from their family, friends, community groups and networks, we will garner greater understanding of the use, benefits, perceptions, and levels of engagement experienced from both a positive and negative perspective by older adults. Several virtual workshops were conducted with end-users recruited via Digital Voice for Communities (based in the Northeast of England) and Digital Communities Wales.
Future workshops will involve demonstrations of existing software available, and prospective prototypes will be shown by paper-based or digital formats. This chapter will contribute to the call because of the methods and approaches ATAT is implementing, through the lens of older adults who have been directly affected by the COVID-19 pandemic. This chapter will provide an insight and a basis for future research teams choosing to engage stakeholders actively and directly into their research
Task Shifting for Scale-up of HIV Care: Evaluation of Nurse-Centered Antiretroviral Treatment at Rural Health Centers in Rwanda
Fabienne Shumbusho and colleagues evaluate a task-shifting model of nurse-centered antiretroviral treatment prescribing in rural primary health centers in Rwanda and find that nurses can effectively and safely prescribe ART when given adequate training, mentoring, and support
K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif
The KRAS oncogene is mutated more frequently in human cancer than any other. The KRAS transcript is alternatively spliced to give rise to two products, K-Ras4A and K-Ras4B, both of which are oncogenic when KRAS is mutated. We detected significant amounts of each transcript in human tumor cells and colorectal carcinomas. We found that K-Ras4A is targeted to the plasma membrane by dual targeting motifs distinct from those of K-Ras4B. Because interfering with membrane association of Ras proteins remains one of the most attractive approaches to anti-Ras therapy, efforts in this direction will have to disrupt both the K-Ras4A and the K-Ras4B membrane-targeting pathways
Mutant N-RAS Protects Colorectal Cancer Cells from Stress-Induced Apoptosis and Contributes to Cancer Development and Progression
N-Ras is one member of a family of oncoproteins that are commonly mutated in cancer. Activating mutations in N-Ras occur in a subset of colorectal cancers, but little in known about how the mutant protein contributes to onset and progression of the disease. Using genetically engineered mice, we find that mutant N-Ras strongly promotes tumorigenesis in the context of inflammation. The pro-tumorigenic nature of mutant N-Ras is related to its anti-apoptotic function, which is mediated by activation of a non-canonical MAPK pathway that signals through Stat3. As a result, inhibition of MEK selectively induces apoptosis in autochthonous colonic tumors expressing mutant N-Ras. The translational significance of this finding is highlighted by our observation that NRAS mutation correlates with a less favorable clinical outcome for colorectal cancer patients. These data demonstrate for the first time the important role that N-Ras plays in colorectal cancer.
Knemidocoptic Mange in Wild Golden Eagles, California, USA
During 2012–2013 in California, USA, 3 wild golden eagles were found with severe skin disease; 2 died. The cause was a rare mite, most closely related to Knemidocoptes derooi mites. Cautionary monitoring of eagle populations, habitats, and diseases is warranted
Genetic Associations With Toxicity-related Discontinuation of Aromatase Inhibitor Therapy for Breast Cancer
Up to 25 % of patients discontinue adjuvant aromatase inhibitor (AI) therapy due to intolerable symptoms. Predictors of which patients will be unable to tolerate these medications have not been defined. We hypothesized that inherited variants in candidate genes are associated with treatment discontinuation because of AI-associated toxicity. We prospectively evaluated reasons for treatment discontinuation in women with hormone receptor-positive breast cancer initiating adjuvant AI through a multicenter, prospective, randomized clinical trial of exemestane versus letrozole. Using multiple genetic models, we evaluated potential associations between discontinuation of AI therapy because of toxicity and 138 variants in 24 candidate genes, selected a priori, primarily with roles in estrogen metabolism and signaling. To account for multiple comparisons, statistical significance was defined as p < 0.00036. Of the 467 enrolled patients with available germline DNA, 152 (33 %) discontinued AI therapy because of toxicity. Using a recessive statistical model, an intronic variant in ESR1 (rs9322336) was associated with increased risk of musculoskeletal toxicity-related exemestane discontinuation [HR 5.0 (95 % CI 2.1-11.8), p < 0.0002]. An inherited variant potentially affecting estrogen signaling may be associated with exemestane-associated toxicity, which could partially account for intra-patient differences in AI tolerability. Validation of this finding is required
- …